Vanguard Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162M | Buy |
5,110,780
+411,427
| +9% | +$13M | ﹤0.01% | 1610 |
|
|
2025
Q1 | $156M | Sell |
4,699,353
-34,256
| -0.7% | -$1.14M | ﹤0.01% | 1585 |
|
|
2024
Q4 | $163M | Buy |
4,733,609
+1,262,362
| +36% | +$43.4M | ﹤0.01% | 1635 |
|
|
2024
Q3 | $139M | Sell |
3,471,247
-48,140
| -1% | -$1.93M | ﹤0.01% | 1727 |
|
|
2024
Q2 | $106M | Sell |
3,519,387
-108,838
| -3% | -$3.28M | ﹤0.01% | 1805 |
|
|
2024
Q1 | $122M | Sell |
3,628,225
-46,539
| -1% | -$1.56M | ﹤0.01% | 1763 |
|
|
2023
Q4 | $119M | Sell |
3,674,764
-9,388
| -0.3% | -$303K | ﹤0.01% | 1774 |
|
|
2023
Q3 | $121M | Buy |
3,684,152
+88,295
| +2% | +$2.89M | ﹤0.01% | 1703 |
|
|
2023
Q2 | $127M | Buy |
3,595,857
+60,572
| +2% | +$2.13M | ﹤0.01% | 1725 |
|
|
2023
Q1 | $115M | Buy |
3,535,285
+280,644
| +9% | +$9.16M | ﹤0.01% | 1759 |
|
|
2022
Q4 | $179M | Buy |
3,254,641
+251,185
| +8% | +$13.8M | ﹤0.01% | 1491 |
|
|
2022
Q3 | $133M | Buy |
3,003,456
+38,958
| +1% | +$1.73M | ﹤0.01% | 1624 |
|
|
2022
Q2 | $145M | Buy |
2,964,498
+261,985
| +10% | +$12.8M | ﹤0.01% | 1615 |
|
|
2022
Q1 | $131M | Buy |
2,702,513
+43,428
| +2% | +$2.11M | ﹤0.01% | 1789 |
|
|
2021
Q4 | $113M | Sell |
2,659,085
-440,856
| -14% | -$18.8M | ﹤0.01% | 1919 |
|
|
2021
Q3 | $119M | Buy |
3,099,941
+1,938,066
| +167% | +$74.3M | ﹤0.01% | 1897 |
|
|
2021
Q2 | $32.8M | Buy |
1,161,875
+350,935
| +43% | +$9.91M | ﹤0.01% | 2583 |
|
|
2021
Q1 | $26.8M | Buy |
810,940
+642,758
| +382% | +$21.2M | ﹤0.01% | 2626 |
|
|
2020
Q4 | $6.08M | Buy |
+168,182
| New | +$6.08M | ﹤0.01% | 3264 |
|